Scholar Rock (SRRK) announced that new efficacy and safety data from the Phase 3 pivotal SAPPHIRE trial will be presented in multiple clinical presentations at the 2025 Muscular Dystrophy ...
SC Future Scholar 529 (Direct) Age-Based Aggressive Track 6-7 Years 8.13 SC Future Scholar Advisor 529 Age-Based Moderate 4-5 Years I 8.28 Indices Commodities Currencies Stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback